Hansa Biopharma AB (HNSBF)
2.90
0.00 (0.00%)
USD |
OTCM |
May 15, 16:00
Hansa Biopharma Total Liabilities (Quarterly) : 150.89M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| BONESUPPORT HOLDING AB | 18.89M |
| BioInvent International AB | 10.06M |
| BioArctic AB | 65.97M |
| Swedish Orphan Biovitrum AB | 4.291B |
| Egetis Therapeutics AB | -- |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 122.00M |
| Shareholders Equity (Quarterly) | -28.90M |
| Debt to Equity Ratio | -4.150 |
| Current Ratio | 3.630 |
| Net Debt Paydown Yield | -1.54% |